185 related articles for article (PubMed ID: 37625261)
1. Fungal pathogens and COVID-19.
Singh A; Kaur A; Chowdhary A
Curr Opin Microbiol; 2023 Oct; 75():102365. PubMed ID: 37625261
[TBL] [Abstract][Full Text] [Related]
2. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.
Menia R; Raychaudhuri S; Agarwal C; Taneja J
Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540
[TBL] [Abstract][Full Text] [Related]
3. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
[TBL] [Abstract][Full Text] [Related]
4. The battle against fungi: lessons in antifungal stewardship from COVID 19 times.
Kanj SS; Haddad SF; Meis JF; Verweij PE; Voss A; Rautemaa-Richardson R; Levy-Hara G; Chowdhary A; Ghafur A; Brüggemann R; Bal AM; Schouten J
Int J Antimicrob Agents; 2023 Jul; 62(1):106846. PubMed ID: 37187336
[TBL] [Abstract][Full Text] [Related]
5. Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult.
Sun G; Weiss A; Zhao J; Silver M; DeMaio M; Dehbashi S
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37640409
[TBL] [Abstract][Full Text] [Related]
6. Predisposing factors of important invasive fungal coinfections in COVID-19 patients: a review article.
Zia M; Goli M
J Int Med Res; 2021 Sep; 49(9):3000605211043413. PubMed ID: 34494475
[TBL] [Abstract][Full Text] [Related]
7. The changing epidemiology of fungal infections.
Lass-Flörl C; Steixner S
Mol Aspects Med; 2023 Dec; 94():101215. PubMed ID: 37804792
[TBL] [Abstract][Full Text] [Related]
8. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
[TBL] [Abstract][Full Text] [Related]
9. Post-COVID-19 Fungal Infection in the Aged Population.
Chavda VP; Mishra T; Kamaraj S; Punetha S; Sengupta O; Joshi Y; Vuppu S; Vaghela D; Vora L
Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992139
[TBL] [Abstract][Full Text] [Related]
10. Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes.
Chiurlo M; Mastrangelo A; Ripa M; Scarpellini P
New Microbiol; 2021 Apr; 44(2):71-83. PubMed ID: 34240742
[TBL] [Abstract][Full Text] [Related]
11. Post-COVID fungal infections of maxillofacial region: a systematic review.
Jain A; Taneja S
Oral Maxillofac Surg; 2022 Sep; 26(3):357-363. PubMed ID: 34622312
[TBL] [Abstract][Full Text] [Related]
12. Mucormycosis, past and present: a comprehensive review.
Gupta I; Baranwal P; Singh G; Gupta V
Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978
[TBL] [Abstract][Full Text] [Related]
13. Mucormycosis infection associated with global COVID-19 pandemic - an institutional histopathological study.
Keerthika R; Narwal A; Kamboj M; Devi A; Anand R; N S; Singh V; Agarwal V; Gupta A
Med Oral Patol Oral Cir Bucal; 2023 Mar; 28(2):e99-e107. PubMed ID: 36806020
[TBL] [Abstract][Full Text] [Related]
14. Hospital-treated serious and invasive aspergillosis and candidiasis infections during the COVID-19 pandemic: a retrospective analysis of Hospital Episode Statistics data from England.
Sung AH; Kiely G; Singh JK; Thomas S; Lough J; Smith M
BMJ Open; 2023 May; 13(5):e070537. PubMed ID: 37253500
[TBL] [Abstract][Full Text] [Related]
15. Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review.
Sasani E; Pakdel F; Khodavaisy S; Salehi M; Salami A; Sohrabi M; Aminishakiba P; Amirafzali I; Salami Khaneshan A
Mycopathologia; 2024 Jan; 189(1):10. PubMed ID: 38231407
[TBL] [Abstract][Full Text] [Related]
16. Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.
Jawanda MK; Narula R; Gupta S; Sharma V; Gupta P; Kaur M
Acta Medica (Hradec Kralove); 2021; 64(4):227-231. PubMed ID: 35285446
[TBL] [Abstract][Full Text] [Related]
17. An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic?
Vitale RG; Afeltra J; Seyedmousavi S; Giudicessi SL; Romero SM
Braz J Microbiol; 2022 Jun; 53(2):759-775. PubMed ID: 35315001
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants.
Ezeokoli OT; Gcilitshana O; Pohl CH
J Fungi (Basel); 2021 Jul; 7(7):. PubMed ID: 34356924
[TBL] [Abstract][Full Text] [Related]
19. Fungal infection profile in critically ill COVID-19 patients: a prospective study at a large teaching hospital in a middle-income country.
Negm EM; Mohamed MS; Rabie RA; Fouad WS; Beniamen A; Mosallem A; Tawfik AE; Salama HM
BMC Infect Dis; 2023 Apr; 23(1):246. PubMed ID: 37072718
[TBL] [Abstract][Full Text] [Related]
20. [Invasive fungal infections: aspergillosis, candidiasis, mucormycosis].
Cornely OA
Drug Res (Stuttg); 2014 Nov; 64 Suppl 1():S14-5. PubMed ID: 25423419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
